MazzolaiLTeixido-TuraGLanziS, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J2024; 45: 3538–3700.
McDermottMMGuralnikJMTianL, et al. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol2007; 50: 974–982.
4.
McDermottMMTianLLiuK, et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol2008; 51: 1482–1489.
5.
McDermottMMGreenlandPFerrucciL, et al. Lower extremity performance is associated with daily life physical activity in individuals with and without peripheral arterial disease. J Am Geriatr Soc2002; 50: 247–255.
6.
RahmanHPipinosIIJohanningJM, et al. Claudicating patients with peripheral artery disease have meaningful improvement in walking speed after supervised exercise therapy. J Vasc Surg2021; 74: 1987–1995.
7.
StuckAKBachmannMFullemannP, et al. Effect of testing procedures on gait speed measurement: A systematic review. PLoS One2020; 15: e0234200.
8.
LanziSPousazACalancaLMazzolaiL.Sex-based difference in functional performance and quality of life 1 year after supervised exercise training in patients with symptomatic peripheral artery disease. Vasc Med2025; 30: 423–430.
9.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med2002; 166: 111–117.
10.
BlandJMAltmanDG.Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1986; 1: 307–310.
